Why This Matters for Your Career
Pfizer is hiring 10 roles related to this product
DUTASTERIDE AND TAMSULOSIN HYDROCHLORIDE (dutasteride and tamsulosin hydrochloride) by Pfizer is 5-alpha reductase inhibitors [moa]. Approved for symptomatic benign prostatic hyperplasia (bph) in men with an enlarged prostate, symptomatic bph in men with an enlarged prostate, prostate cancer. First approved in 2014.
5-alpha Reductase Inhibitors
5-alpha Reductase Inhibitor
Worked on DUTASTERIDE AND TAMSULOSIN HYDROCHLORIDE at Pfizer? Share your interview experience or compensation data (+7 days Pro)
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.
Bioavailability Study of Fixed Dose Combination (FDC) Dutasteride and Tamsulosin Hydrochloride (HCl) Relative to One Dutasteride and One Tamsulosin HCl Tablet in Healthy Male Subjects
Comparative Bioavailability of Two Fixed Dose Combination (FDC) Formulations of Dutasteride and Tamsulosin Hydrochloride Relative to Co-administration of Dutasteride With Tamsulosin Hydrochloride in Healthy Male Subjects Under Fed and Fasted States
Bioequivalence Study of the Second Generation Dutasteride and Tamsulosin Hydrochloride (HCL) Combination Capsule in Fasted State
Pfizer is hiring 10 roles related to this product